Impact of China's Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease

• Main Authors: Miao Wang (Author), Jing Liu (Author), Brandon K. Bellows (Author), Yue Qi (Author), Jiayi Sun (Author), Jun Liu (Author), Andrew E. Moran (Author), Dong Zhao (Author)
• Format: Book
• Published: Ubiquity Press, 2020-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Statin medications reduce the risk of atherosclerotic cardiovascular disease (ASCVD). China's new central government medicine procurement policy lowered statin prices by five-fold or more, which may impact the cost-effectiveness of statin therapy. Objective: To explore the impact of...